Vaccination
UK vaccine gambles paid off, while EU caution slowed it down
French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate.
Feb 7, 2021
0
4
Page 17 - News tagged with candidates
Vaccination
Why COVID-19 vaccine research remains critical
While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight ...
Jan 25, 2021
0
2
Diseases, Conditions, Syndromes
Hope for a vaccination against Staphylococcus areus infections?
Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunization against multi-resistant strains is seen ...
Jan 21, 2021
0
3
Diseases, Conditions, Syndromes
NIH officials highlight COVID-19 vaccine facts, unknowns for healthcare providers
Healthcare providers must be able to explain the latest data supporting the safety and efficacy of vaccines for coronavirus disease 2019 (COVID-19) so they can strongly encourage vaccination when appropriate while acknowledging ...
Jan 19, 2021
0
3
Medications
Investigational ALS drug pridopidine enters trial
In 2020, the Sean M. Healey & AMG Center at Massachusetts General Hospital launched the first platform trial for amyotrophic lateral sclerosis (ALS), in which multiple treatments are tested and evaluated simultaneously to ...
Jan 8, 2021
0
2
Diseases, Conditions, Syndromes
Brazilian study says Sinovac COVID-19 jab 78% effective
A vaccine candidate made by China's Sinovac is 78% effective in protecting against COVID-19, according to results of a study announced Thursday by Brazilian state health officials seeking federal approval of the shot.
Jan 7, 2021
0
1
Vaccination
Bayer, CureVac 'join forces' on COVID-19 vaccine
German pharmaceutical firms Bayer and CureVac said Thursday that they have joined forces in the development and supply of CureVac's COVID-19 vaccine candidate.
Jan 7, 2021
0
2
Medical research
Stanford developing single-dose nanoparticle vaccine for COVID-19
Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...
Jan 6, 2021
2
208
Medical research
Natural products with potential efficacy against lethal viruses
Researchers at Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego have broken down the genomic and life history traits of three classes ...
Jan 6, 2021
0
41
Vaccination
As China vaccinates, makers say jab works against mutations
Chinese medics in Shanghai were given COVID-19 inoculations this week, as vaccine makers insisted their jab was effective against current virus mutations.
Jan 5, 2021
0
2
